Compare Mutual Funds

Pros
Among most bought funds within the category.

Among most bought funds within the category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
7/8
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

7 Years 5 Months

13 Years 5 Months

Fund AUM

₹3033 Cr

₹8306 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹100
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.65%

0.91%

Exit Load

0.5%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

33

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(8.79%)
  2. Ipca Laboratories Ltd(8.55%)
  3. Cipla Ltd(8.06%)
  4. Globus Medical Inc Class A(7.69%)
  5. Laurus Labs Ltd(6.5%)
  1. Sun Pharmaceuticals Industries Ltd(13.08%)
  2. Lupin Ltd(7.99%)
  3. Divi's Laboratories Ltd(6.56%)
  4. Dr Reddy's Laboratories Ltd(5.81%)
  5. Cipla Ltd(5.67%)
No of Sectors

3

1

Top 3 Sectors
  1. Health(98.47%)
  2. Financial Services(1.53%)
  3. Tech(0%)

Health

(100%)

Equity %

98.94%

99.7%

Debt %

-

-

P/E

34.36

35.73

P/B

4.64

5.7

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-2.65%

-2.91%

3-Month Return

-5.91%

-1.77%

6-Month Return

-4.82%

-1.1%

1-Year Return

-1.59%

3.24%

3-Year Return

22.94%

24.53%

5-Year Return

16.26%

16.64%

Sharpe

1.12

1.17

Alpha

0.24

0.22

Beta

0.83

0.9

Standard Deviation

14.58

15.21

Information Ratio

-0.57

-0.47

Description

DSP Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Chirag Dagli

Sailesh Raj Bhan, Kinjal Desai, Lokesh Maru, Divya Sharma

Most Popular Comparisons